Fundies.
English

Segment disclosures

Company overview

China BCT Pharmacy Group, Inc.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

4 dimension combinations 48 retained observations 8 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Manufacturing

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cnbi:ManufacturingMember
PeriodValueUnitFiledEvidence
2013-01-01 – 2013-03-313570227 USD20130520Open filing evidence
2012-01-01 – 2012-12-3114274377 USD20130415Open filing evidence
2012-07-01 – 2012-09-303263322 USD20121115Open filing evidence
2012-01-01 – 2012-09-3010984990 USD20121115Open filing evidence
2012-04-01 – 2012-06-303728085 USD20120817Open filing evidence
2012-01-01 – 2012-06-307721668 USD20120817Open filing evidence
2012-01-01 – 2012-03-313993583 USD20130520Open filing evidence
2011-01-01 – 2011-12-3113557626 USD20130415Open filing evidence
2011-07-01 – 2011-09-303558828 USD20121115Open filing evidence
2011-01-01 – 2011-09-309832462 USD20121115Open filing evidence
2011-04-01 – 2011-06-303470922 USD20120817Open filing evidence
2011-01-01 – 2011-06-306273634 USD20120817Open filing evidence

Pharmaceutical Distribution

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cnbi:PharmaceuticalDistributionMember
PeriodValueUnitFiledEvidence
2013-01-01 – 2013-03-3148666237 USD20130520Open filing evidence
2012-01-01 – 2012-12-31172634681 USD20130415Open filing evidence
2012-07-01 – 2012-09-3038609852 USD20121115Open filing evidence
2012-01-01 – 2012-09-30135377511 USD20121115Open filing evidence
2012-04-01 – 2012-06-3043505861 USD20120817Open filing evidence
2012-01-01 – 2012-06-3096767659 USD20120817Open filing evidence
2012-01-01 – 2012-03-3153261798 USD20130520Open filing evidence
2011-01-01 – 2011-12-31190662940 USD20130415Open filing evidence
2011-07-01 – 2011-09-3050220352 USD20121115Open filing evidence
2011-01-01 – 2011-09-30141964773 USD20121115Open filing evidence
2011-04-01 – 2011-06-3048493250 USD20120817Open filing evidence
2011-01-01 – 2011-06-3091744421 USD20120817Open filing evidence

Retail Pharmacy

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=cnbi:RetailPharmacyMember
PeriodValueUnitFiledEvidence
2013-01-01 – 2013-03-3114340828 USD20130520Open filing evidence
2012-01-01 – 2012-12-3154960289 USD20130415Open filing evidence
2012-07-01 – 2012-09-3013529595 USD20121115Open filing evidence
2012-01-01 – 2012-09-3041383587 USD20121115Open filing evidence
2012-04-01 – 2012-06-3013864014 USD20120817Open filing evidence
2012-01-01 – 2012-06-3027853992 USD20120817Open filing evidence
2012-01-01 – 2012-03-3113989978 USD20130520Open filing evidence
2011-01-01 – 2011-12-3153266572 USD20130415Open filing evidence
2011-07-01 – 2011-09-3013701532 USD20121115Open filing evidence
2011-01-01 – 2011-09-3039402465 USD20121115Open filing evidence
2011-04-01 – 2011-06-3013151576 USD20120817Open filing evidence
2011-01-01 – 2011-06-3025700933 USD20120817Open filing evidence

Unallocated Amount To Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=us-gaap:UnallocatedAmountToSegmentMember
PeriodValueUnitFiledEvidence
2013-01-01 – 2013-03-3166577292 USD20130520Open filing evidence
2012-01-01 – 2012-12-31241869347 USD20130415Open filing evidence
2012-07-01 – 2012-09-3055402769 USD20121115Open filing evidence
2012-01-01 – 2012-09-30187746088 USD20121115Open filing evidence
2012-04-01 – 2012-06-3061097960 USD20120817Open filing evidence
2012-01-01 – 2012-06-30132343319 USD20120817Open filing evidence
2012-01-01 – 2012-03-3171245359 USD20130520Open filing evidence
2011-01-01 – 2011-12-31257487138 USD20130415Open filing evidence
2011-07-01 – 2011-09-3067480712 USD20121115Open filing evidence
2011-01-01 – 2011-09-30191199700 USD20121115Open filing evidence
2011-04-01 – 2011-06-3065115748 USD20120817Open filing evidence
2011-01-01 – 2011-06-30123718988 USD20120817Open filing evidence